GT Biopharma Inc GTBP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:04 PM EDT
3.17quote price arrow up+0.12 (+3.93%)
Volume
11,797
52 week range
2.95 - 16.11
Loading...
  • Open3.04
  • Day High3.21
  • Day Low3.04
  • Prev Close3.05
  • 52 Week High16.11
  • 52 Week High Date06/06/23
  • 52 Week Low2.95
  • 52 Week Low Date04/30/24

Key Stats

  • Market Cap4.377M
  • Shares Out1.38M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-58.56

KEY STATS

  • Open3.04
  • Day High3.21
  • Day Low3.04
  • Prev Close3.05
  • 52 Week High16.11
  • 52 Week High Date06/06/23
  • 52 Week Low2.95
  • 52 Week Low Date04/30/24
  • Market Cap4.377M
  • Shares Out1.38M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-58.56

RATIOS/PROFITABILITY

  • EPS (TTM)-7.04
  • P/E (TTM)-0.45
  • Fwd P/E (NTM)-0.29
  • EBITDA (TTM)-13.576M
  • ROE (TTM)-79.10%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GT Biopharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. Its TriKE platform generates therapeutics designed to harness and enhance the cancer killing abilities of a patient’s own natural killer (NK) cells. The Company is also using its TriKE platform to develop therapeutics...
Michael Breen
Executive Chairman of the Board, Interim Chief Executive Officer
Manu Ohri
Chief Financial Officer, Company Secretary
Address
8000 MARINA BLVD, SUITE 100
Brisbane, CA
94005
United States

Top Peers

SYMBOLLASTCHG%CHG
NAVB
Navidea Biopharmaceuticals Inc
0.036+0.011+44.00%
AVTX
Avalo Therapeutics Inc
10.29-0.11-1.01%
TRVN
Trevena Inc
0.4175-0.0026-0.6189%
BXRXQ
Baudax Bio Inc
0.0086+0.0006+7.00%
TLPH
Talphera Inc
1.16-0.06-4.94%